Prospera Financial Services’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$651K Buy
7,855
+2,510
+47% +$208K 0.01% 815
2025
Q1
$434K Buy
5,345
+2,021
+61% +$164K 0.01% 836
2024
Q4
$299K Buy
3,324
+100
+3% +$9.01K 0.01% 933
2024
Q3
$319K Sell
3,224
-1,677
-34% -$166K 0.01% 900
2024
Q2
$454K Sell
4,901
-9,727
-66% -$902K 0.01% 741
2024
Q1
$1.39M Sell
14,628
-40,423
-73% -$3.84M 0.04% 415
2023
Q4
$4.92M Buy
55,051
+257
+0.5% +$22.9K 0.16% 142
2023
Q3
$4M Sell
54,794
-3,721
-6% -$272K 0.15% 148
2023
Q2
$4.87M Sell
58,515
-38,878
-40% -$3.23M 0.19% 127
2023
Q1
$7.42M Sell
97,393
-88,629
-48% -$6.75M 0.31% 72
2022
Q4
$15.4M Buy
186,022
+10,473
+6% +$869K 0.77% 19
2022
Q3
$13.9M Buy
175,549
+148,625
+552% +$11.8M 0.73% 19
2022
Q2
$2M Buy
26,924
+22,012
+448% +$1.64M 0.1% 243
2022
Q1
$442K Buy
4,912
+1,044
+27% +$93.9K 0.02% 630
2021
Q4
$434K Buy
3,868
+400
+12% +$44.9K 0.02% 611
2021
Q3
$436K Sell
3,468
-90
-3% -$11.3K 0.02% 569
2021
Q2
$482K Hold
3,558
0.02% 545
2021
Q1
$483K Buy
3,558
+258
+8% +$35K 0.03% 496
2020
Q4
$464K Buy
3,300
+788
+31% +$111K 0.03% 435
2020
Q3
$280K Sell
2,512
-824
-25% -$91.8K 0.11% 169
2020
Q2
$373K Buy
3,336
+209
+7% +$23.4K 0.03% 403
2020
Q1
$242K Hold
3,127
0.03% 441
2019
Q4
$297K Buy
+3,127
New +$297K 0.02% 485
2017
Q4
Sell
-6,585
Closed -$580K 451
2017
Q3
$580K Sell
6,585
-625
-9% -$55K 0.09% 213
2017
Q2
$562K Buy
+7,210
New +$562K 0.09% 199
2017
Q1
Sell
-11,495
Closed -$716K 423
2016
Q4
$716K Buy
+11,495
New +$716K 0.14% 132